Medications for Venous Thromboembolism

4 results

  • fragmin

    (Dalteparin Sodium)
    Pfizer Laboratories Div Pfizer Inc
    FRAGMIN is indicated for the prophylaxis of ischemic complications in unstable angina and non-Q-wave myocardial infarction, deep vein thrombosis (DVT) prevention in surgical and at-risk patients, extended treatment of symptomatic VTE in cancer patients, and VTE treatment in pediatric patients. It is not for acute VTE treatment.

  • pradaxa

    (dabigatran etexilate mesylate)
    Boehringer Ingelheim Pharmaceuticals Inc.
    PRADAXA Capsules are indicated for reducing the risk of stroke and systemic embolism in adults with non-valvular atrial fibrillation, treating deep venous thrombosis and pulmonary embolism in adults, prophylaxis post-hip replacement surgery, and treating and preventing venous thromboembolic events in pediatric patients aged 8 to less than 18 years.

  • xarelto

    (rivaroxaban)
    Janssen Pharmaceuticals, Inc.
    XARELTO is indicated for reducing stroke and systemic embolism in nonvalvular atrial fibrillation, treating deep vein thrombosis and pulmonary embolism, preventing recurrence of these conditions, and offering prophylaxis in post-surgery and hospitalized patients. It also reduces major cardiovascular events in patients with coronary artery disease and peripheral artery disease.

  • xarelto

    (rivaroxaban)
    Cardinal Health 107, LLC
    XARELTO is indicated for reducing the risk of stroke and systemic embolism in nonvalvular atrial fibrillation, treating deep vein thrombosis (DVT) and pulmonary embolism (PE), preventing DVT post-surgery, and pediatric thromboprophylaxis. It also reduces major cardiovascular events in coronary artery disease and thrombotic events in peripheral artery disease patients.